Picture of Small Pharma logo

DMT Small Pharma Income Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Annual income statement for Small Pharma, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.

2020
February 28th
2021
February 28th
2022
February 28th
2023
February 28th
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:
fx
Final
fx
Final
FinalFinal
Revenue
Total Revenue0.1590.07800
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses0.9035.7320.624.7
Operating Profit-0.744-5.66-20.6-24.7
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-0.744-7.02-22.9-24.7
Provision for Income Taxes
Net Income After Taxes-0.553-7.03-22.3-22.8
Net Income Before Extraordinary Items
Net Income-0.553-7.03-22.3-22.8
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.553-7.03-22.3-22.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.008-0.102-0.066-0.071
Dividends per Share